clinical trial · NCT05411887
Study to Evaluate the Effect of Improving Systolic BP and LDL-C Compared to Conventional Treatments and the Convenience of Taking Medication of Olostar Tab
Daewoong Pharmaceutical Co. LTD.·—·active not recruiting·n = 2,845
HyperlipidemiasHypertensionRosuvastatin, Olmesartan Medoxomil
brief summary
The purpose of this study is to evaluate the effectiveness of Olostar Tablet on blood pressure and lipid profiles, obtain safety-related information for subgroups that failed to participate in the clinical trials, and to evaluate variables that affect treatment effectiveness.
started
Jun 20, 2022
primary completion
Mar 31, 2025
completion
Dec 31, 2025
last updated
Aug 24, 2025
official title
A Non-interventional, Multi Center, Prospective Observational Study to Evaluate the Effect of Improving Systolic Blood Pressure and Low-density Lipoprotein Cholesterol Compared to Conventional Treatments and the Convenience of Taking Medication of Olostar Tab. in Patients With Essential Hypertension and Dyslipidemia.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol